Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trialM. Bolla, M. Piérart, Abraham Kuten et al.|The Lancet|2002Cited by 1.7k
Improved Survival in Patients with Locally Advanced Prostate Cancer Treated with Radiotherapy and GoserelinM. Bolla, M. Piérart, Dionisio González et al.|New England Journal of Medicine|1997Cited by 1.6k
External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised studyM. Bolla, Laurence Collette, Geertjan van Tienhoven et al.|The Lancet Oncology|2010Cited by 944
A phase III randomized trial of intermittent versus continuous androgen suppression for PSA progression after radical therapy (NCIC CTG PR.7/SWOG JPR.7/CTSU JPR.7/ UK Intercontinental Trial CRUKE/01/013).Juanita Crook, Laurence Klotz, Chris J. O’Callaghan et al.|Journal of Clinical Oncology|2011Cited by 51